MIND4-19

CAS No. 129544-85-0

MIND4-19( —— )

Catalog No. M29018 CAS No. 129544-85-0

4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]- is an inhibitor of SIRT2 with antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 60 In Stock
10MG 98 In Stock
25MG 205 In Stock
50MG 335 In Stock
100MG 537 In Stock
200MG 758 In Stock
500MG 1134 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MIND4-19
  • Note
    Research use only, not for human use.
  • Brief Description
    4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]- is an inhibitor of SIRT2 with antitumor activity.
  • Description
    4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]- is an inhibitor of SIRT2 with antitumor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Sirtuin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    129544-85-0
  • Formula Weight
    373.47
  • Molecular Formula
    C22H19N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (267.76 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Thiomyristoyl

    Thiomyristoyl is a highly selective and potent SIRT2 inhibitor with IC50 of 28 nM.

  • Benzamide, 3-methoxy...

    Benzamide, 3-methoxy-N-(3-thiazolo[5,4-b]pyridin-2-ylphenyl) is a sirtuin modulator and useful for increasing the lifespan of a cell, and treating and?/or preventing a wide variety of diseases and disorders including diabetes, cardiovascular disease.

  • Pristimerin

    Pristimerin has anticancer activity, treatment with Pristimerin may be a potential strategy for the suppression of hypoxia-induced metastasis through the reversal of hypoxia-induced stem cell characteristics and EMT in cancer cells.